{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:24:34Z","timestamp":1787156674206,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtha.2026.05.032","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:01:15Z","timestamp":1780556475000},"page":"3392-3404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of women with type 2B von Willebrand disease during pregnancy and postpartum: guidance from ISTH SSC subcommittees on von Willebrand factor and women\u2019s health issues in thrombosis and hemostasis"],"prefix":"10.1016","volume":"24","author":[{"given":"Predrag","family":"Miljic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Noureldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analia","family":"Sanchez-Luceros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezan","family":"Abdul-Kadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross I.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sidonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7562-203X","authenticated-orcid":false,"given":"Maha","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.05.032_bib1","series-title":"Von Willebrand disease: basic and clinical aspects","first-page":"91","article-title":"Clinical aspects of von Willebrand disease: bleeding history","author":"James","year":"2011"},{"key":"10.1016\/j.jtha.2026.05.032_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1538-7836.2003.00523.x","article-title":"Type IIB von Willebrand disease: a paradox explains how von Willebrand factor works","volume":"2","author":"Ruggeri","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1055\/s-0036-1579638","article-title":"Type 2B von Willebrand disease: a matter of plasma plus platelet abnormality","volume":"42","author":"Castaman","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib4","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI109795","article-title":"Variant von Willebrand\u2019s disease: characterization of two subtypes by analysis of multimeric composition of factor VIII\/von Willebrand factor in plasma and platelets","volume":"65","author":"Ruggeri","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.05.032_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179566","article-title":"Type 2B von Willebrand disease with or without large multimers: a distinction of the two sides of the disorder is long overdue","volume":"12","author":"Casonato","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2026.05.032_bib6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jtha.2023.01.012","article-title":"Genetic determinants of enhanced von Willebrand factor clearance from plasma","volume":"21","author":"Seidizadeh","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib7","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood-2013-03-493312","article-title":"Accelerated uptake of VWF\/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopenia","volume":"122","author":"Casari","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.032_bib8","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1073\/pnas.86.10.3793","article-title":"von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets","volume":"86","author":"de Groot","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2026.05.032_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1538-7836.2007.02296.x","article-title":"Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13","volume":"5","author":"Rayes","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"Federici","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.032_bib11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand\u2019s disease","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.05.032_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/asheducation.V2012.1.161.3798231","article-title":"Making a diagnosis of VWD","volume":"2012","author":"Branchford","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2026.05.032_bib13","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1538-7836.2010.03864.x","article-title":"Health-related quality of life among adult patients with moderate and severe von Willebrand disease","volume":"8","author":"de Wee","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0041-1723797","article-title":"Current challenges in the peripartum management of women with von Willebrand disease","volume":"47","author":"Byrne","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2141.1987.00349.x","article-title":"Type IIB von Willebrand\u2019s disease presenting as thrombocytopenia during pregnancy","volume":"67","author":"Giles","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.032_bib16","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1172\/JCI69458","article-title":"von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin \u03b1IIb\u03b23","volume":"123","author":"Casari","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.05.032_bib17","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1172\/JCI73169","article-title":"Thrombocytopathy and type 2B von Willebrand disease","volume":"123","author":"Ware","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.05.032_bib18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM198310063091402","article-title":"Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand\u2019s disease","volume":"309","author":"Holmberg","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.05.032_bib19","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1016\/j.jtha.2024.08.028","article-title":"WiN study group. Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study","volume":"22","author":"van Kwawegen","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jtha.2022.10.019","volume":"21","author":"Miljic","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ejh.13250","article-title":"Pregnancy and delivery in women with von Willebrand disease","volume":"103","author":"Castaman","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtha.2026.05.032_bib22","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1111\/hae.12580","article-title":"Management of pregnancy in type 2B von Willebrand disease: case report and literature review","volume":"21","author":"Biguzzi","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.05.032_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0041-1723799","article-title":"Type 2B von Willebrand disease in pregnancy: a systematic literature review","volume":"47","author":"Makhamreh","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.techfore.2005.09.005","article-title":"RT Delphi: an efficient, \u201cround-less\u201d almost real time Delphi method","volume":"73","author":"Gordon","year":"2006","journal-title":"Technol Forecast Soc Change"},{"key":"10.1016\/j.jtha.2026.05.032_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13063-021-05074-2","article-title":"Multi-round compared to real-time Delphi for consensus in core outcome set (COS) development: a randomised trial","volume":"22","author":"Quirke","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.jtha.2026.05.032_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/978-1-4939-7196-1_35","article-title":"Ristocetin-induced platelet aggregation (RIPA) and RIPA mixing studies","volume":"1646","author":"Frontroth","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jtha.2026.05.032_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12635","article-title":"2B von Willebrand disease diagnosis: considerations reflecting on 2021 multisociety guidelines","volume":"5","author":"Othman","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.032_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ajh.2830350107","article-title":"Effect of a factor VIII concentrate on type IIB von Willebrand\u2019s disease-associated thrombocytopenia presenting during pregnancy in identical twin mothers","volume":"35","author":"Ieko","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.05.032_bib31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1538-7836.2005.01150.x","article-title":"von Willebrand disease and pregnancy","volume":"3","author":"Kujovich","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0038-1660080","article-title":"Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension","volume":"54","author":"Morrison","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.thromres.2005.01.009","article-title":"Platelet activation in pregnancy-induced hypertension","volume":"116","author":"Karalis","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.05.032_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-0033-1353442","article-title":"Platelet-type von Willebrand disease: new insights into the molecular pathophysiology of a unique platelet defect","volume":"39","author":"Othman","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MPH.0000000000000741","article-title":"Type 2B von Willebrand disease: an unusual case of severe neonatal thrombocytopenia","volume":"39","author":"Rotz","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtha.2026.05.032_bib36","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/bloodadvances.2018017418","article-title":"Significant gynecological bleeding in women with low von Willebrand factor levels","volume":"2","author":"Lavin","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.032_bib37","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1111\/hae.12739","article-title":"Postpartum haemorrhage in women with von Willebrand disease: an observational study of the Pennsylvania Health Care Cost Containment Council (PHC4) database","volume":"21","author":"Malec","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.05.032_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2516.2003.00712.x","article-title":"Type 2B vWD: the varied clinical manifestations in two kindreds","volume":"9","author":"Mathew","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.05.032_bib39","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2516.2011.02691.x","article-title":"Pregnancy in type 2B VWD: a case series","volume":"18","author":"Ranger","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.05.032_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1586\/17474086.2014.868771","article-title":"An update on type 2B von Willebrand disease","volume":"7","author":"Mikhail","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtha.2026.05.032_bib41","first-page":"e193","article-title":"Green-top Guideline No. 71 (joint with UKHCDO)","volume":"124","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.jtha.2026.05.032_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.032_bib43","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood-2017-06-742692","article-title":"How I treat type 2B von Willebrand disease","volume":"131","author":"Kruse-Jarres","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.032_bib44","first-page":"254","article-title":"Current approaches to pregnancy and childbirth in women with von Willebrand disease","volume":"16","author":"Johnsen","year":"2018","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.jtha.2026.05.032_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2516.2006.01314.x","article-title":"The obstetric and gynaecological management of women with inherited bleeding disorders\u2013review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors\u2019 Organization","volume":"12","author":"Lee","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.05.032_bib46","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/hematology.2021000321","article-title":"Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy","volume":"2021","author":"Turan","year":"2021","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2026.05.032_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/pbc.26168","article-title":"Management of type 2b von Willebrand disease in the neonatal period","volume":"64","author":"Proud","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtha.2026.05.032_bib48","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/jth.13414","article-title":"Dynamic platelet function on von Willebrand factor is different in preterm neonates and full-term neonates: changes in neonatal platelet function","volume":"14","author":"Cowman","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib49","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/s-0036-1587686","article-title":"Von Willebrand disease and pregnancy: a review of evidence and expert opinion","volume":"42","author":"Reynen","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.annfar.2012.10.032","article-title":"[Epidural labor analgesia and parturient with type 2B von Willebrand disease]","volume":"32","author":"Lagarrigue","year":"2013","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.jtha.2026.05.032_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.05.032_bib52","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.032_bib53","first-page":"117","article-title":"Evidence-based recommendations on the treatment of von Willebrand disease in Italy","volume":"7","author":"Mannucci","year":"2009","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtha.2026.05.032_bib54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/hae.12635","article-title":"Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey","volume":"21","author":"Stoof","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.05.032_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100633","article-title":"Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease: a systematic review","volume":"39","author":"Punt","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2026.05.032_bib56","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood.2019000964","article-title":"How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease","volume":"136","author":"Leebeek","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.032_bib57","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/hae.13067","article-title":"Obstetric bleeding among women with inherited bleeding disorders: a retrospective study","volume":"22","author":"Hawke","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.05.032_bib58","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00000542-200412000-00029","article-title":"Severe thrombocytopenia, type 2B von Willebrand disease and pregnancy","volume":"101","author":"Hepner","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2026.05.032_bib59","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1160\/TH11-03-0180","article-title":"Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease","volume":"106","author":"De Wee","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib60","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood.V79.10.2507.bloodjournal79102507","article-title":"Molecular genetics of von Willebrand disease","volume":"79","author":"Ginsburg","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.032_bib61","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1745-6215-11-40","article-title":"The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial","volume":"11","author":"Shakur","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.jtha.2026.05.032_bib63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/bfm.2014.0027","article-title":"Outcome following tranexamic acid exposure during breastfeeding","volume":"9","author":"Gilad","year":"2014","journal-title":"Breastfeed Med"},{"key":"10.1016\/j.jtha.2026.05.032_bib64","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jtha.2023.03.046","article-title":"Challenges in management of women with type 2B von Willebrand disease during pregnancy and postpartum: evidence from literature and data from International Registry and Physicians Survey-communication from the SSC of the ISTH: comment from Comerford et al","volume":"21","author":"Comerford","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.032_bib65","first-page":"257","article-title":"von Willebrand disease and pregnancy","volume":"9","author":"Roqu\u00e9","year":"2000","journal-title":"J Matern Fetal Med"},{"key":"10.1016\/j.jtha.2026.05.032_bib66","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/hae.12115","article-title":"The effect of labour on the coagulation system in the term neonate","volume":"19","author":"Kulkarni","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.05.032_bib67","author":"Wilkinson"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:29:17Z","timestamp":1787153357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626003569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":66,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1538783626003569"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.05.032","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of women with type 2B von Willebrand disease during pregnancy and postpartum: guidance from ISTH SSC subcommittees on von Willebrand factor and women\u2019s health issues in thrombosis and hemostasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}